http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 26 Oct 2026 08:51:57 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html <p align="justify">PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+The+Simply+Good+Foods+Compan/27231400.html Mon, 26 Oct 2026 08:51:57 -0400 AARD ERAS PSIX SMPL http://www.streetinsider.com/Options/Power+Solutions+%28PSIX%29+call+put+ratio+1+call+to+10.8+puts+with+a+focus+on+2500+contracts+of+November+45+puts/27222259.html <p>Power Solutions (NASDAQ: PSIX) 30-day option implied volatility is at 100; compared to its 52-week range of 65 to 160. Call put ratio 1 call to 10.8 puts with a focus on 2500 contracts of November 45 puts.</p> http://www.streetinsider.com/Options/Power+Solutions+%28PSIX%29+call+put+ratio+1+call+to+10.8+puts+with+a+focus+on+2500+contracts+of+November+45+puts/27222259.html Thu, 22 Oct 2026 15:16:37 -0400 PSIX http://www.streetinsider.com/Corporate+News/Power+Solutions+International+refreshes+its+corporate+logo/27214578.html <p>Power Solutions International, Inc. (Nasdaq: PSIX) announced the introduction of a refreshed corporate logo, which the company says marks a milestone in the rollout of its Power Boost 2030 strategy.</p><p>The Wood Dale, Illinois-based company, which designs, engineers, and manufactures power systems and enclosures, said the updated visual identity accompanies what it is calling "PSI 2.0," a phase intended to expand its focus on the data center power market while maintaining its existing industrial and oil and gas operations.</p><p>According to a press release, the company said the logo change reflects a broader strategic direction toward becoming a more technology-driven power solutions http://www.streetinsider.com/Corporate+News/Power+Solutions+International+refreshes+its+corporate+logo/27214578.html Wed, 21 Oct 2026 10:01:10 -0400 PSIX http://www.streetinsider.com/Press+Releases/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html <p><strong>A New Look. A New Era. A New Journey Forward.</strong></p><p>WOOD DALE, Ill., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (Nasdaq: PSIX) (“PSI”), a leader in the design, engineering, and manufacturing of advanced power solutions and state-of-the-art enclosures, today announced the introduction of its refreshed corporate logo, marking an important milestone in the rollout of its <strong>Power Boost 2030</strong> vision and strategy.</p> <p>The refreshed identity opens a new chapter—<strong>PSI 2.0</strong>—as the Company builds on its established industrial and oil and gas expertise and accelerates its strategic focus on the growing data center power market. The new logo http://www.streetinsider.com/Press+Releases/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html Wed, 21 Oct 2026 10:00:00 -0400 PSIX http://www.streetinsider.com/Globe+Newswire/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html <p><strong>A New Look. A New Era. A New Journey Forward.</strong></p><p>WOOD DALE, Ill., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (Nasdaq: PSIX) (“PSI”), a leader in the design, engineering, and manufacturing of advanced power solutions and state-of-the-art enclosures, today announced the introduction of its refreshed corporate logo, marking an important milestone in the rollout of its <strong>Power Boost 2030</strong> vision and strategy.</p> <p>The refreshed identity opens a new chapter—<strong>PSI 2.0</strong>—as the Company builds on its established industrial and oil and gas expertise and accelerates its strategic focus on the growing data center power market. The new logo http://www.streetinsider.com/Globe+Newswire/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html Wed, 21 Oct 2026 10:00:00 -0400 PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX